Patient engagement is important, but so is the engagement of doctors and medical personal delivering the protocol to the patient. Gerald Wayne Dryden, Jr., MD, PhD from the University of Louisville discusses patient engagement in a special edition of Pharma 15 Live! with fellow panelists Linda A. Glaser, MD, PhD from Coastal Biomedical Research, Inc. and Annie Finstein, a clinical trial participant.
What basic information and support might a patient need when considering a clinical trial? Clinical trial participant Annie Finstein shares her perspective alongside a panel of doctors at the CHI SCOPE Summit 2019 in this special edition of Pharma15 Live!
Joining Annie are guest panelists Gerald Wayne Dryden, Jr., MD, PhD, MSPH, M.Sc. from the University of Louisville, and Linda A. Glaser, MD, PhD from Coastal Biomedical Research, Inc.
BBK hosted its signature Pharma15 Live! debate series to the 10th Annual SCOPE Summit on February 19, 2019. Bonnie A. Brescia moderated a panel of doctors and patient during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?”
We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.
Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.
While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.
What is most rewarding to you as you consider your contribution to clinical trial research?
The ability to help advance science and treat disease.
How do you define patient engagement? What does that term mean to you?
In an age where patients have more choice about treatment options (just think about how the treatment guidelines have evolved for multiple sclerosis or rheumatoid arthritis in the last 10 years for example,) and more clinical trials are being conducted by fewer investigators, there has been a constant upward pressure on competition for clinical trial patients, even as sponsors and third party recruitment companies becomes more innovative and proactive in their approaches to marketing their trials.
BBK Worldwide is very excited to be participating in the Cambridge Health Institute’s 7th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 23 – 25 in Miami FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 12 different conferences, 4 pre-conference workshops and 2 symposia.
Following last week’s successful mHealth + Patient Engagement webinar, which featured Larry Suarez, mobile architect with Oracle’s Health Sciences Global Business Unit and Daniel Bender, product manager with Empatica, we are excited to offer our latest Focus 5 eBook – a compilation of industry expert insights on the ways in which mobile health technology impacts clinical trials, raises the patient voice, and enables a higher standard of care.
We’re incredibly proud to have our My Protocol Pal (SM) mobile app and site engagement platform featured in PharmaVOICE’s inaugural Innovation issue, out today. Designed to recognize organizations that are breaking new ground, the issue celebrates “the culture of innovation and achievement across the global healthcare/pharmaceutical industry spectrum.
The global operating environment for trials continues to become more competitive and complex. As a result, demand for new approaches and solutions to improve site engagement and patient enrollment has increased dramatically. Remaining at the top of the list, among the many other challenges sponsors face today is making sure sites have real-time access to the right study information and materials. Despite today’s increasingly competitive landscape, when the study community has what it needs to be and stay informed, the right patients enroll, and enrollment happens on schedule.